Heparin-induced overexpression of basic fibroblast growth factor, basic fibroblast growth factor receptor, and cell-associated proteoheparan sulfate in cultured coronary smooth muscle cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 8, 1996, Pages 1063-1069

  Skaletz Rorowski, Adriatic ^a   Schmidt, Annette ^a   Breithardt, Günter ^a,b   Buddecke, Eckhart ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

bFGF; bFGF receptor; coronary smooth muscle cells; heparan sulfate; heparin

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; HEPARAN SULFATE; HEPARIN; PROTEOHEPARAN SULFATE;

ANIMAL CELL; ARTERIOSCLEROSIS; ARTICLE; CELL CYCLE; DOSE RESPONSE; GENE EXPRESSION; HEART MUSCLE CELL; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; SIGNAL TRANSDUCTION;

EID: 0029843993     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.8.1063     Document Type: Article

References (37)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Gospodarowicz D, Ferrara N, Haaparanta T, Neufeld G. Basic fibroblast growth factor: expression in cultured bovine vascular smooth muscle cells. Eur J Cell Biol. 1988;46:144-151.
3. Lindner V, Olson NE, Clowes AW, Reidy A. Inhibition of smooth muscle cell proliferation in injured rat arteries: interaction of heparin with basic fibroblast growth factor. J Clin Invest. 1992;90:2044-2049.
4. Klagsbrun M, Edelman ER. Biological and biochemical properties of fibroblast growth factors: implications for the pathogenesis of atherosclerosis. Arteriosclerosis. 1989;9:269-278.
5. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA. 1991;88:3739-3743.
6. Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem. 1989;58:575-606.
7. Schmidt A, Skaletz-Rorowski A, Breithardt A, Buddecke E. Growth status-dependent changes of bFGF compartmentalization and heparan sulfate structure in arterial smooth muscle cells. Eur J Cell Biol. 1995;67:130-134.
8. Aviezer D, Levy E, Safran M, Svahn C, Buddecke E, Schmidt A, David G, Vlodavsky I, Yayon A. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J Biol Chem. 1994;269:114-121.
9. Habuchi H, Suzuki S, Saito T, Tamura T, Harada T, Yoshida K, Kimata J. Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor. Biochem J. 1992;285:805-813.
10. Walker A, Turnbull JE, Gallagher JT. Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor. J Biol Chem. 1994;269:931-935.
11. Castellot JJ, Addonizio ML, Rosenberg RD, Karnovsky MJ. Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth. J Cell Biol. 1981;90:372-379.
12. Hoover RL, Rosenberg RD, Haering W, Karnovsky MJ. Inhibition of rat arterial smooth muscle cell proliferation by heparin, II: in vitro studies. Circ Res. 1980;47:578-583.
13. Guyton JR, Rosenberg RD, Clowes AW, Karnovsky MJ. Inhibition of rat arterial smooth muscle cell proliferation by heparin, I: in vivo studies with anticoagulant and non-anti-coagulant heparin. Circ Res. 1980;46:625-634.
14. Clowes AW, Karnovsky MJ. Suppression of smooth muscle cell proliferation in injured arteries. Nature. 1977;265:625-626.
15. Ishihara M, Shaklee PN, Yang Z, Liang W, Wie Z, Stack RJ, Holme K. Structural features in heparin which modulate specific biological activities mediated by basic fibroblast growth factor. Glycobiology. 1994;4:451-458.
16. Wright TC, Pukac LA, Castellot JJ, Karnovsky MJ, Levine RA, Kim-Park HY, Campisi J. Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway. Proc Natl Acad Sci USA. 1989;86:3199-3203.
17. Pukac LA, Ottlinger ME, Karnovsky MJ. Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells. J Biol Chem. 1992;267:3707-3711.
18. Bennett MR, Littlewood TL, Hancock DC, Evan GI, Newby AC. Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest? Biochem J. 1994;302:701-708.
19. Hamon M, Bauters C, Wernert N, Courtin P, Delcayre C, Adamantidis M, Lablanche JM, Bertrand ME, Dupuis B, Swynghedauw B. Heparin does not inhibit oncogene induction in rabbit aorta following balloon denudation. Cardiovasc Res. 1993;27:1209-1213.
20. Grainger DJ, Witchell CM, Watson JV, Metcalfe JC, Weissberg PL. Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor beta-like activity from serum. Cardiovasc Res. 1993;27:2238-2247.
21. Schmidt A, Buddecke E. Cell-associated proteoheparan sulfate from bovine arterial smooth muscle cells. Exp Cell Res. 1988;178:242-253.
22. 1 peak. Cytometry. 1987;8:1-8.
23. Tata JR. Isolation of nuclei from liver and other tissues. Methods Enzymol. 1974;31:253-262.
24. Oegema TR, Hascall VC, Dziewiatkowski DD. Isolation and characterization of proteoglycans from swarm rat chondrosarcoma. J Biol Chem. 1975;250:6151-6159.
25. Saito H, Yamagata T, Suzuki S. Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates. J Biol Chem. 1968;243:1536-1542.
26. Schmidt A, Yoshida K, Buddecke E. The antiproliferative activity of arterial heparan sulfate resides in domains enriched with 2-O-sulfated uronic acid residues. J Biol Chem. 1992;267:19242-19247.
27. Schmidt A, Lemming G, Yoshida K, Buddecke E. Molecular organization and antiproliferative domains of arterial tissue heparan sulfate. Eur J Cell Biol. 1992;59:322-328.
28. Guimond S, Maccarana M, Olwin BB, Lindahl U, Rapraeger AC. Activating and inhibitory heparin sequences for FGF-2 (basic-FGF). J Biol Chem. 1993;268:23906-23914.
29. Clowes AW, Clowes MM. Kinetics of cellular proliferation after arterial injury, II: inhibition of smooth muscle growth by heparin. Lab Invest. 1985;52:611-616.
30. Majesky MW, Schwartz SM, Clowes MM, Clowes AW. Heparin regulates smooth muscle S phase entry in the injured rat carotid artery. Circ Res. 1987;61:296-300.
31. Castellot JJ, Pukac LA, Caleb BL, Wright TC, Karnovsky MJ. Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells. J Cell Biol. 1989;109:3147-3155.
32. Castellot JJ, Wong K, Herman B, Hoover RL, Albertini DF, Wright TC, Caleb BL, Karnovsky MJ. Binding and internalization of heparin by vascular smooth muscle cells. J Cell Physiol. 1985;124:13-20.
33. Herbert JM, Maffrand JP. Heparin interactions with cultured human vascular endothelial and smooth muscle cells: incidence on vascular smooth muscle cell proliferation. J Cell Physiol 1989;138:424-432.
34. Roghani M, Moscatelli D. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J Biol Chem. 1992;267:22156-22162.
35. Vijayagopal P, Ciolino HP, Radhakrishnamurty B, Berenson GS. Heparin stimulates proteoglycan synthesis by vascular smooth muscle cells while suppressing cellular proliferation. Atherosclerosis. 1992;94:135-146.
36. Nikkari ST, Järveläinen HT, Wight TN, Ferguson M, Clowes AW. Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am J Pathol 1994;144:1348-1356.
37. More RS, Brack MJ, Gershlick AH. Heparin after angioplasty: an unresolved issue? Eur Heart J. 1993;14:1543-1547.